PEA may be an effective sleep aid, says recent study

Results showed that while there were no differences between the two groups when it came to sleep quantity and quality, the PEA group did experience reduced sleep onset latency, time to feel completely awake, and improved cognition on waking.

A recent randomized, double-blind, placebo-controlled study1 found that supplementation with palmitoylethanolamide (PEA) may help with support healthy sleep. In the study, 103 adults were given either placebo of PEA in the form of Levagen+ from Gencor, daily for eight weeks. Sleep quality and quantity were measured using wrist actigraphy, a sleep diary, and questionnaires. Results showed that while there were no differences between the two groups when it came to sleep quantity and quality, the PEA group did experience reduced sleep onset latency, time to feel completely awake, and improved cognition on waking.

“We are extremely pleased by the results from the PEA group reporting falling asleep faster and waking up the next day feeling more alert and awake without the grogginess and other cognitive impairments,” said Chase Shryoc, vice president of sales & business development for Gencor, in a press release. “It is encouraging to see the efficacy of Levagen+ as an effective sleep aid.”

Levagen+ can be used in effervescent tablets, ready-to-drink shots, functional foods, functional beverages, gummies, and more.

Reference

  1. Rao A et al. “Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study.” Sleep Science and Practice, vol. 5 (2021)